AUSTIN BENNION: Open Payments
NPI 1285249318 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,336 in 103 payments from 23 companies in 2025. Trend: 2023 $1,884 · 2024 $1,393 · 2025 $2,336
Food & beverage: $2,029Education: $307
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 13 | $365 |
| ABBVIE INC. | 14 | $277 |
| Sumitomo Pharma America, Inc. | 15 | $251 |
| Janssen Biotech, Inc. | 7 | $196 |
| PFIZER INC. | 9 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $155 |
| Endo USA, Inc. | 6 | $112 |
| Dornier MedTech America, Inc | 1 | $110 |
| 180 Medical, Inc. | 3 | $96 |
| Dendreon Pharmaceuticals LLC | 3 | $77 |
Products named: XTANDI, BOTOX, ERLEADA, Nubeqa, GEMTESA, Dornier MedTech, ORGOVYX, AVEED.
Industry payments across UT — which companies pay providers there.
